Equities research analysts predict that Encompass Health Corp (NYSE:EHC) will announce $0.89 earnings per share for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Encompass Health’s earnings, with the highest EPS estimate coming in at $0.92 and the lowest estimate coming in at $0.86. Encompass Health posted earnings per share of $0.91 in the same quarter last year, which would suggest a negative year-over-year growth rate of 2.2%. The business is scheduled to issue its next quarterly earnings results on Monday, November 4th.
According to Zacks, analysts expect that Encompass Health will report full year earnings of $3.82 per share for the current year, with EPS estimates ranging from $3.68 to $3.94. For the next year, analysts forecast that the business will post earnings of $3.71 per share, with EPS estimates ranging from $3.61 to $4.00. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research analysts that follow Encompass Health.
Several brokerages have recently weighed in on EHC. BMO Capital Markets began coverage on shares of Encompass Health in a research report on Thursday, June 27th. They set an “outperform” rating and a $72.00 target price on the stock. Raymond James decreased their target price on shares of Encompass Health from $80.00 to $75.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 31st. Finally, Barclays upgraded shares of Encompass Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $68.00 to $70.00 in a research report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Encompass Health has a consensus rating of “Buy” and an average price target of $75.75.
Shares of Encompass Health stock traded down $1.57 during trading on Monday, hitting $61.61. 271,330 shares of the company’s stock traded hands, compared to its average volume of 817,666. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 1.87. The business’s fifty day simple moving average is $63.82. Encompass Health has a twelve month low of $56.74 and a twelve month high of $82.46. The firm has a market cap of $6.33 billion, a P/E ratio of 16.97, a PEG ratio of 2.11 and a beta of 0.83.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be given a $0.28 dividend. The ex-dividend date of this dividend is Monday, September 30th. This is a positive change from Encompass Health’s previous quarterly dividend of $0.27. This represents a $1.12 dividend on an annualized basis and a yield of 1.82%. Encompass Health’s payout ratio is 29.75%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: What is operating income?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.